Skip to main content

Severe weather warning in your area. Please stay indoors and stay safe. Read more

General Comprehensive Hereditary Cancer Panel

Test Information

Title
General Comprehensive Hereditary Cancer Panel
Category
Cancer
Test Name (CMS Title)
Hereditary Comprehensive Cancer
Gene/Platform/Region List
AIP, APC, ATM, AXIN2, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CHEK2, CTNNA1, DICER1, EGFR, EGLN1, EPCAM, EXT1, EXT2, FH, FLCN, GALNT12, GREM1, HOXB13, KIT, LZTR1, MAX, MEN1, MET, MITF, MLH1, MLH3, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NF2, NTHL1, PALB2, PDGFRA, PMS2, POLD1, POLE, POT1, PRKAR1A, PTCH1, PTEN, RAD51C, RAD51D, RB1, RECQL, RET, RNF43, RPS20, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, SMARCA4, SMARCB1, SMARCE1, STK11, SUFU, TMEM127, TP53, TSC1, TSC2, VHL
Test type
Samples Accepted
Blood
Indications
Diagnosis, Carrier Cascade Testing
Test Methodology
Sequencing
Methodology Notes
EPCAM and GREM1 CNV only
Disease/Condition
Comprehensive Cancer Panel (76 genes)

Last Updated: December 09, 2025